Elisa Bisi Lin

Ms. Elisa Bisi Lin

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2015 in Journal of Organometallic Chemistry
Verified
Journal Article
Closed access
MMMichael G. Manas
Michael G. Manas
LSLiam S. Sharninghausen
Liam S. Sharninghausen
ELElisa Bisi Lin
Elisa Bisi Lin
RCRobert H. Crabtree
Robert H. Crabtree

15 February 2023 in Seminars in Diagnostic Pathology
Verified
Journal Article
Closed access
ELElisa Bisi Lin
Elisa Bisi Lin
FFFranklin Fuda
Franklin Fuda
HLHung S Luu
Hung S Luu
ACAndrew M. Cox
Andrew M. Cox
FFFengqi Fang
Fengqi Fang
MCMingyi Chen
Mingyi Chen

21 January 2025 in International Journal of Laboratory Hematology
Verified
Journal Article
Closed access
SSSujata Sajjan
Sujata Sajjan
EOEstelle E. Oertling
Estelle E. Oertling
FFFranklin Fuda
Franklin Fuda
JGJeffrey Gagan
Jeffrey Gagan
PKPrasad Koduru
Prasad Koduru
WCWeina Chen
Weina Chen

11 July 2022 in Hematology Reports
Verified
Journal Article
Open access
PDF file
ELElisa Bisi Lin
Elisa Bisi Lin
EAEllen Araj
Ellen Araj
JMJohn Markantonis
John Markantonis
HLHung S Luu
Hung S Luu
MCMingyi Chen
Mingyi Chen
Introduction: This review summarizes data from patients with COVID-19 requiring intensive care unit (ICU) admission. The goals of this study are to showcase some morphological anomalies found in peripheral blood smears from COVID-19 patients and to bring attention to how some hematologic abnormalities in COVID-19 that correspond to disease severity and mortality. Methods: We performed a retrospective analysis of hematologic parameters using peripheral blood smear analysis from 31 COVID-19 patients hospitalized between April 2021 and January 2022. Results: We found abnormal morphology that has not been previously reported. We also report that severe lymphopenia, neutrophilia, acute hemolysis, hematologic malignancies, and increased LDH are associated with ICU admissions, respiratory failure requiring intubation, and poor clinical outcome. Conclusion: We propose these recommendations in the management of COVID-19 patients: 1. Early diagnosis and follow-up of DIC; 2. Optimization of thromboprophylaxis regimen.